BRENTUXIMAB VEDOTIN

BRENTUXIMAB VEDOTIN was reported 10402 times

BRENTUXIMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES REFRACTORY 8 0.6667
1 PERIPHERAL BLOOD STEM CELL APHERESIS 10 0.6250
2 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT 15 0.5357
3 ADRENAL INFARCTION 14 0.5000
4 ANAPLASTIC LARGE-CELL LYMPHOMA 86 0.3644
5 HAEMATOPOIETIC STEM CELL MOBILISATION 17 0.2656
6 CUTANEOUS T-CELL LYMPHOMA REFRACTORY 5 0.2381
7 ELECTROCARDIOGRAM HIGH VOLTAGE 4 0.2222
8 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 64 0.2184
9 HEPATITIS G 6 0.2143
10 PARANEOPLASTIC RASH 6 0.2143
11 CUTANEOUS T-CELL LYMPHOMA RECURRENT 10 0.1587
12 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 92 0.1551
13 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 10 0.1493
14 T-CELL LYMPHOMA STAGE IV 8 0.1404
15 ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 8 0.1311
16 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 35 0.1115
17 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
18 PROCALCITONIN ABNORMAL 6 0.0857
19 PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0851
20 APOPTOTIC COLONOPATHY 7 0.0843
21 CANCER FATIGUE 16 0.0672
22 LARYNGEAL DYSPNOEA 14 0.0611
23 CONGENITAL APLASIA 19 0.0611
24 AXONAL AND DEMYELINATING POLYNEUROPATHY 6 0.0588
25 ESCHERICHIA PYELONEPHRITIS 14 0.0541
26 LEUKODYSTROPHY 5 0.0538
27 BETA 2 MICROGLOBULIN INCREASED 14 0.0536
28 ACUTE POLYNEUROPATHY 13 0.0455
29 BILE ACIDS INCREASED 8 0.0452
30 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 27 0.0449
31 PERIPHERAL MOTOR NEUROPATHY 62 0.0442
32 ACANTHAMOEBA INFECTION 8 0.0426
33 INTERLEUKIN-2 RECEPTOR INCREASED 7 0.0409
34 CUTANEOUS T-CELL LYMPHOMA 48 0.0381
35 RASH SCARLATINIFORM 8 0.0362
36 GLUTAMATE DEHYDROGENASE INCREASED 4 0.0360
37 PERIPHERAL SENSORIMOTOR NEUROPATHY 45 0.0358
38 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 4 0.0342
39 CLOSTRIDIUM BACTERAEMIA 7 0.0327
40 CYTOMEGALOVIRUS CHORIORETINITIS 62 0.0318
41 ECTROPION 10 0.0297
42 VARICELLA ZOSTER PNEUMONIA 5 0.0287
43 ACQUIRED DIAPHRAGMATIC EVENTRATION 10 0.0282
44 MYCOSIS FUNGOIDES 22 0.0267
45 BLOOD LACTATE DEHYDROGENASE ABNORMAL 18 0.0265
46 MUCOCUTANEOUS ULCERATION 6 0.0264
47 TRACHEAL FISTULA 4 0.0260
48 BLOOD ALBUMIN ABNORMAL 13 0.0250
49 PERIPHERAL SENSORY NEUROPATHY 145 0.0248
50 GASTROINTESTINAL MUCORMYCOSIS 4 0.0240
51 HEPATITIS VIRAL 19 0.0237
52 MUCOSAL TOXICITY 6 0.0221
53 DISTAL INTESTINAL OBSTRUCTION SYNDROME 7 0.0208
54 LYMPHOMATOID PAPULOSIS 6 0.0205
55 CUTANEOUS LYMPHOMA 4 0.0196
56 VISUAL ACUITY REDUCED TRANSIENTLY 6 0.0195
57 SERUM FERRITIN ABNORMAL 6 0.0187
58 BLOOD STEM CELL TRANSPLANT FAILURE 4 0.0186
59 T-CELL LYMPHOMA 21 0.0183
60 PRODUCT TEMPERATURE EXCURSION ISSUE 94 0.0183
61 GASTROENTERITIS BACTERIAL 6 0.0182
62 POLYNEUROPATHY 213 0.0178
63 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 4 0.0174
64 ILEAL PERFORATION 11 0.0166
65 TUMOUR FLARE 11 0.0161
66 PNEUMATOSIS 7 0.0157
67 MEDIASTINAL MASS 6 0.0157
68 FEBRILE BONE MARROW APLASIA 66 0.0155
69 PNEUMOCYSTIS JIROVECII PNEUMONIA 142 0.0141
70 VASOGENIC CEREBRAL OEDEMA 10 0.0139
71 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
72 BICYTOPENIA 26 0.0133
73 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
74 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 18 0.0125
75 ASPARTATE AMINOTRANSFERASE ABNORMAL 19 0.0125
76 BLOOD ALKALINE PHOSPHATASE ABNORMAL 11 0.0122
77 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 4 0.0122
78 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 16 0.0121
79 CANDIDA TEST POSITIVE 5 0.0120
80 HYPOGONADISM 12 0.0119
81 FEBRILE NEUTROPENIA 776 0.0117
82 NEUTROPENIC INFECTION 11 0.0115
83 HYPERLEUKOCYTOSIS 10 0.0113
84 COMPLICATIONS OF BONE MARROW TRANSPLANT 4 0.0111
85 HODGKIN'S DISEASE 8 0.0110
86 CEREBRAL MASS EFFECT 4 0.0110
87 ENTEROBACTER SEPSIS 4 0.0108
88 DEMYELINATING POLYNEUROPATHY 11 0.0107
89 ABDOMINAL LYMPHADENOPATHY 9 0.0104
90 DERMATITIS EXFOLIATIVE GENERALISED 35 0.0101
91 RETICULOCYTE COUNT INCREASED 8 0.0099
92 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 9 0.0097
93 VENOOCCLUSIVE DISEASE 24 0.0096
94 KLEBSIELLA BACTERAEMIA 9 0.0095
95 MOLLUSCUM CONTAGIOSUM 5 0.0093
96 SARCOPENIA 4 0.0092
97 KLEBSIELLA TEST POSITIVE 6 0.0092
98 CYTOMEGALOVIRUS COLITIS 21 0.0091
99 ALANINE AMINOTRANSFERASE ABNORMAL 19 0.0090
100 AUTONOMIC NEUROPATHY 9 0.0089
101 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0088
102 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 73 0.0088
103 CYTOKINE STORM 6 0.0088
104 BLOOD FIBRINOGEN DECREASED 10 0.0088
105 PROTHROMBIN TIME ABNORMAL 6 0.0087
106 FEBRILE INFECTION 10 0.0085
107 AUTOIMMUNE MYOSITIS 4 0.0085
108 ESCHERICHIA TEST POSITIVE 10 0.0083
109 VISCERAL LEISHMANIASIS 6 0.0083
110 SUPERIOR VENA CAVA SYNDROME 5 0.0083
111 EPSTEIN-BARR VIRAEMIA 9 0.0081
112 ELECTROLYTE DEPLETION 4 0.0081
113 PULMONARY TOXICITY 56 0.0079
114 CYTOMEGALOVIRUS INFECTION REACTIVATION 34 0.0077
115 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 39 0.0077
116 INFECTIOUS COLITIS 4 0.0076
117 NEUROPATHY PERIPHERAL 725 0.0076
118 WHITE BLOOD CELL DISORDER 20 0.0075
119 TYPE IV HYPERSENSITIVITY REACTION 20 0.0073
120 NEUTROPENIC SEPSIS 52 0.0073
121 GROIN INFECTION 4 0.0073
122 GUILLAIN-BARRE SYNDROME 35 0.0072
123 MYELOSUPPRESSION 259 0.0072
124 CYTOPENIA 86 0.0070
125 CARDIORENAL SYNDROME 4 0.0070
126 SECOND PRIMARY MALIGNANCY 58 0.0070
127 DIFFUSE ALVEOLAR DAMAGE 8 0.0070
128 GRAFT VERSUS HOST DISEASE 50 0.0069
129 EOSINOPHILIC PNEUMONIA ACUTE 6 0.0069
130 PERIPHERAL NERVE INJURY 6 0.0068
131 ENGRAFTMENT SYNDROME 4 0.0068
132 AMYLASE INCREASED 25 0.0068
133 CORNEAL DEPOSITS 5 0.0067
134 ILEUS PARALYTIC 30 0.0067
135 TUMOUR LYSIS SYNDROME 59 0.0067
136 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
137 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 50 0.0067
138 STEM CELL TRANSPLANT 16 0.0064
139 HYPOPROTEINAEMIA 12 0.0063
140 VASCULAR PAIN 6 0.0063
141 TRACHEO-OESOPHAGEAL FISTULA 4 0.0063
142 NEOPLASM RECURRENCE 21 0.0062
143 MENINGITIS ASEPTIC 27 0.0060
144 MIXED LIVER INJURY 18 0.0060
145 ESCHERICHIA SEPSIS 17 0.0059
146 MYELITIS 9 0.0058
147 HYPERTHERMIA 44 0.0058
148 DIFFUSE LARGE B-CELL LYMPHOMA 44 0.0057
149 VENTRICULAR HYPOKINESIA 18 0.0056
150 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
151 WHITE MATTER LESION 7 0.0055
152 TOXIC LEUKOENCEPHALOPATHY 4 0.0055
153 ENTEROCOLITIS INFECTIOUS 5 0.0054
154 OPPORTUNISTIC INFECTION 10 0.0054
155 HYPOALBUMINAEMIA 42 0.0054
156 ADENOCARCINOMA GASTRIC 5 0.0054
157 BLOOD LACTATE DEHYDROGENASE INCREASED 85 0.0054
158 OBLITERATIVE BRONCHIOLITIS 7 0.0053
159 MICROANGIOPATHY 5 0.0053
160 NEUTROPENIC COLITIS 11 0.0053
161 DISSEMINATED CRYPTOCOCCOSIS 4 0.0053
162 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 5 0.0053
163 MUCOSAL INFLAMMATION 138 0.0053
164 CYTOMEGALOVIRUS INFECTION 87 0.0052
165 CARBON DIOXIDE DECREASED 6 0.0052
166 INTERCEPTED MEDICATION ERROR 24 0.0052
167 PNEUMONITIS 141 0.0052
168 HAEMATOTOXICITY 49 0.0052
169 C-REACTIVE PROTEIN ABNORMAL 33 0.0051
170 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9 0.0051
171 BLOOD FIBRINOGEN INCREASED 4 0.0051
172 PNEUMONIA FUNGAL 20 0.0051
173 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
174 GASTROINTESTINAL TOXICITY 24 0.0050
175 MYOSITIS 44 0.0049
176 PNEUMONIA KLEBSIELLA 9 0.0049
177 PSEUDOMONAS TEST POSITIVE 4 0.0049
178 NEUTROPHIL COUNT DECREASED 199 0.0049
179 GRANULOCYTE COUNT DECREASED 9 0.0048
180 HAEMOGLOBIN ABNORMAL 31 0.0048
181 GASTROINTESTINAL PERFORATION 20 0.0048
182 ESCHERICHIA BACTERAEMIA 11 0.0047
183 EPSTEIN-BARR VIRUS INFECTION 29 0.0046
184 HYPERURICAEMIA 19 0.0046
185 APLASIA 9 0.0046
186 CLOSTRIDIUM DIFFICILE COLITIS 48 0.0045
187 PARAPARESIS 8 0.0045
188 MEGACOLON 7 0.0045
189 NEUTROPENIA 599 0.0044
190 HYPERSENSITIVITY PNEUMONITIS 5 0.0044
191 BRONCHOPULMONARY ASPERGILLOSIS 34 0.0044
192 MENINGITIS VIRAL 6 0.0044
193 INSULIN RESISTANCE 9 0.0043
194 THERAPY PARTIAL RESPONDER 67 0.0043
195 CEREBRAL TOXOPLASMOSIS 4 0.0043
196 PROCALCITONIN INCREASED 5 0.0043
197 SENSE OF OPPRESSION 5 0.0042
198 PNEUMONIA CRYPTOCOCCAL 4 0.0042
199 FIBRIN D DIMER INCREASED 15 0.0042
200 STREPTOCOCCAL SEPSIS 5 0.0042
201 HEPATORENAL SYNDROME 7 0.0041
202 EPIDERMAL NECROSIS 4 0.0041
203 ACUTE MYELOID LEUKAEMIA 64 0.0041
204 GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0041
205 PERONEAL NERVE PALSY 23 0.0040
206 SYSTEMIC CANDIDA 10 0.0040
207 NEUTROPHIL PERCENTAGE INCREASED 5 0.0040
208 LYMPHOPENIA 56 0.0040
209 GENITAL HERPES 6 0.0039
210 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
211 LYMPHOCYTE COUNT DECREASED 69 0.0039
212 SEPTIC SHOCK 169 0.0039
213 MONOPARESIS 7 0.0039
214 NEOPLASM PROGRESSION 132 0.0038
215 PNEUMOPERITONEUM 7 0.0038
216 ILEUS 46 0.0037
217 NEUROTOXICITY 64 0.0036
218 ENTEROCOLITIS 21 0.0036
219 BLOOD CALCIUM ABNORMAL 6 0.0036
220 PSEUDOMEMBRANOUS COLITIS 8 0.0036
221 LUNG CONSOLIDATION 10 0.0036
222 BACTERAEMIA 42 0.0035
223 NEUTROPHIL COUNT ABNORMAL 10 0.0035
224 THROMBOCYTOPENIA 388 0.0035
225 LOCALISED OEDEMA 16 0.0035
226 BONE MARROW FAILURE 70 0.0034
227 MENINGITIS CRYPTOCOCCAL 6 0.0034
228 GASTROINTESTINAL NECROSIS 10 0.0034
229 SYSTEMIC MYCOSIS 4 0.0034
230 RESTRICTIVE PULMONARY DISEASE 4 0.0034
231 LIPASE INCREASED 26 0.0034
232 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
233 SUBILEUS 7 0.0034
234 PNEUMONIA INFLUENZAL 4 0.0034
235 COLITIS 127 0.0033
236 LYMPHADENITIS 8 0.0033
237 BLOOD URIC ACID INCREASED 19 0.0033
238 MONOCYTE COUNT DECREASED 4 0.0033
239 SOFT TISSUE INFECTION 6 0.0033
240 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0033
241 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
242 LEUKOPENIA 159 0.0032
243 PLATELET DISORDER 8 0.0032
244 PANCYTOPENIA 177 0.0032
245 BONE MARROW TRANSPLANT 6 0.0032
246 EXTRAVASATION 13 0.0032
247 NON-CARDIAC CHEST PAIN 10 0.0032
248 ABDOMINAL INFECTION 8 0.0031
249 JC VIRUS INFECTION 5 0.0031
250 HYPOPHOSPHATAEMIA 23 0.0031
251 BILIARY OBSTRUCTION 4 0.0031
252 CARDIOVASCULAR INSUFFICIENCY 5 0.0031
253 ORGANISING PNEUMONIA 15 0.0030
254 IGA NEPHROPATHY 5 0.0030
255 AREFLEXIA 8 0.0030
256 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
257 DISEASE PROGRESSION 352 0.0030
258 ENTERITIS 19 0.0030
259 ANAL ABSCESS 16 0.0030
260 MALIGNANT PLEURAL EFFUSION 5 0.0030
261 EFFUSION 4 0.0029
262 PSEUDOMONAS INFECTION 25 0.0029
263 HEPATIC CYTOLYSIS 37 0.0029
264 GAMMA-GLUTAMYLTRANSFERASE INCREASED 64 0.0029
265 HAEMATOLOGICAL INFECTION 7 0.0029
266 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
267 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
268 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 6 0.0028
269 VENOUS THROMBOSIS 11 0.0028
270 AGRANULOCYTOSIS 52 0.0028
271 LYMPHOMA 43 0.0028
272 HYPERTRIGLYCERIDAEMIA 16 0.0027
273 HEPATOSPLENOMEGALY 7 0.0027
274 LYMPHOPROLIFERATIVE DISORDER 8 0.0027
275 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 26 0.0027
276 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
277 BLOOD CHLORIDE DECREASED 7 0.0027
278 PURPURA 24 0.0027
279 FAILURE TO THRIVE 14 0.0027
280 HEPATITIS FULMINANT 8 0.0027
281 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
282 LUNG OPACITY 7 0.0027
283 EMBOLISM 22 0.0026
284 PLATELET COUNT ABNORMAL 16 0.0026
285 VENOOCCLUSIVE LIVER DISEASE 13 0.0026
286 LICHENOID KERATOSIS 6 0.0026
287 MYCOBACTERIUM AVIUM COMPLEX INFECTION 7 0.0026
288 NEPHROPATHY TOXIC 29 0.0026
289 TOXIC SKIN ERUPTION 26 0.0026
290 CARDIOTOXICITY 23 0.0026
291 ORAL FUNGAL INFECTION 7 0.0026
292 PROSTATOMEGALY 10 0.0025
293 ACUTE RESPIRATORY DISTRESS SYNDROME 45 0.0025
294 DIPLEGIA 5 0.0025
295 CELL DEATH 5 0.0025
296 RASH MACULO-PAPULAR 56 0.0025
297 DIVERTICULUM INTESTINAL 11 0.0025
298 DEVICE RELATED SEPSIS 5 0.0025
299 SMALL INTESTINAL HAEMORRHAGE 5 0.0025
300 MONOCYTE COUNT INCREASED 9 0.0025
301 CYTOMEGALOVIRUS VIRAEMIA 11 0.0025
302 WHITE BLOOD CELL COUNT DECREASED 268 0.0025
303 RECURRENT CANCER 10 0.0024
304 MALIGNANT NEOPLASM PROGRESSION 251 0.0024
305 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
306 HYPERGLYCAEMIA 89 0.0024
307 PAPILLOEDEMA 11 0.0024
308 STAPHYLOCOCCAL SEPSIS 12 0.0024
309 ANAPHYLACTOID REACTION 10 0.0024
310 ALANINE AMINOTRANSFERASE INCREASED 149 0.0024
311 CAPILLARY LEAK SYNDROME 5 0.0024
312 HYPERBILIRUBINAEMIA 25 0.0024
313 BEHAVIOUR DISORDER 13 0.0024
314 IMMUNE THROMBOCYTOPENIA 11 0.0024
315 SEPSIS 267 0.0024
316 ATELECTASIS 23 0.0024
317 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
318 ENTERITIS INFECTIOUS 4 0.0023
319 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
320 RADIATION PNEUMONITIS 5 0.0023
321 STREPTOCOCCAL INFECTION 13 0.0023
322 HYPERPHOSPHATAEMIA 5 0.0023
323 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
324 PANCREATITIS ACUTE 52 0.0023
325 HEPATITIS TOXIC 6 0.0023
326 APLASTIC ANAEMIA 12 0.0023
327 HEPATOTOXICITY 51 0.0023
328 DYSAESTHESIA 7 0.0023
329 SERUM FERRITIN INCREASED 12 0.0023
330 CLOSTRIDIUM TEST POSITIVE 5 0.0023
331 HEPATOCELLULAR INJURY 32 0.0023
332 ANAPHYLACTIC SHOCK 58 0.0022
333 JUGULAR VEIN THROMBOSIS 4 0.0022
334 TEMPERATURE REGULATION DISORDER 5 0.0022
335 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
336 HYPERLACTACIDAEMIA 6 0.0022
337 PNEUMOMEDIASTINUM 4 0.0022
338 ODYNOPHAGIA 13 0.0022
339 TRANSAMINASES INCREASED 48 0.0022
340 RENAL FUNCTION TEST ABNORMAL 10 0.0022
341 BILIRUBIN CONJUGATED INCREASED 5 0.0021
342 PROTEIN TOTAL DECREASED 8 0.0021
343 HYPOKALAEMIA 98 0.0021
344 HEPATITIS 54 0.0021
345 ASPARTATE AMINOTRANSFERASE INCREASED 112 0.0021
346 CLOSTRIDIUM DIFFICILE INFECTION 46 0.0021
347 PNEUMATOSIS INTESTINALIS 6 0.0021
348 DUODENAL ULCER HAEMORRHAGE 6 0.0021
349 ANAEMIA 399 0.0021
350 SHOCK HAEMORRHAGIC 17 0.0021
351 NON-SMALL CELL LUNG CANCER 10 0.0021
352 PARAPLEGIA 6 0.0021
353 ELECTROLYTE IMBALANCE 24 0.0021
354 LYMPHADENOPATHY 73 0.0021
355 C-REACTIVE PROTEIN INCREASED 75 0.0021
356 SPLENOMEGALY 24 0.0020
357 SINUS TACHYCARDIA 29 0.0020
358 PERICARDIAL EFFUSION 47 0.0020
359 CARDIOMYOPATHY 30 0.0020
360 PYREXIA 694 0.0020
361 VASCULAR DEVICE INFECTION 9 0.0020
362 ACUTE HEPATIC FAILURE 27 0.0020
363 ORAL CANDIDIASIS 26 0.0020
364 IMMUNE-MEDIATED HEPATITIS 4 0.0020
365 QUADRIPLEGIA 4 0.0019
366 DERMATITIS BULLOUS 14 0.0019
367 VENTRICULAR DYSFUNCTION 5 0.0019
368 LUNG INFILTRATION 17 0.0019
369 CANDIDA INFECTION 32 0.0019
370 SARCOIDOSIS 9 0.0019
371 HEPATITIS B REACTIVATION 6 0.0019
372 PNEUMONIA VIRAL 6 0.0019
373 CARDIAC DYSFUNCTION 7 0.0019
374 LEUKOENCEPHALOPATHY 7 0.0019
375 ENCEPHALITIS 13 0.0019
376 EJECTION FRACTION DECREASED 29 0.0019
377 HYPOCALCAEMIA 35 0.0018
378 CHOLECYSTITIS 22 0.0018
379 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
380 INFUSION RELATED REACTION 120 0.0018
381 LUNG INFECTION 28 0.0018
382 RESPIRATORY FAILURE 131 0.0018
383 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
384 CLOSTRIDIAL INFECTION 6 0.0018
385 ANAPHYLACTIC REACTION 98 0.0018
386 ACUTE RESPIRATORY FAILURE 34 0.0018
387 OXYGEN SATURATION ABNORMAL 5 0.0018
388 NEUTROPHIL COUNT INCREASED 18 0.0018
389 OESOPHAGEAL CANDIDIASIS 7 0.0018
390 CYTOKINE RELEASE SYNDROME 35 0.0017
391 NIGHT SWEATS 56 0.0017
392 HERPES VIRUS INFECTION 10 0.0017
393 TONSILLITIS 9 0.0017
394 TYPE I HYPERSENSITIVITY 6 0.0017
395 ESCHERICHIA INFECTION 14 0.0017
396 INTERSTITIAL LUNG DISEASE 82 0.0017
397 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
398 DEVICE RELATED INFECTION 26 0.0017
399 HEPATIC FUNCTION ABNORMAL 63 0.0017
400 PLATELET COUNT DECREASED 178 0.0017
401 BLOOD CULTURE POSITIVE 5 0.0017
402 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
403 UROSEPSIS 15 0.0016
404 HYPERCALCAEMIA 20 0.0016
405 INFLAMMATORY MARKER INCREASED 8 0.0016
406 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0016
407 EOSINOPHILIC PNEUMONIA 5 0.0016
408 HYPERTRANSAMINASAEMIA 11 0.0016
409 BLOOD CREATINE INCREASED 7 0.0016
410 TESTICULAR PAIN 5 0.0016
411 ACUTE CORONARY SYNDROME 13 0.0016
412 GASTROINTESTINAL INFECTION 14 0.0016
413 OESOPHAGITIS 17 0.0016
414 BLOOD BILIRUBIN INCREASED 42 0.0016
415 OFF LABEL USE 1358 0.0015
416 SUSPECTED OFF LABEL USE 7 0.0015
417 LIVER INJURY 38 0.0015
418 BACTERIAL SEPSIS 5 0.0015
419 COVID-19 PNEUMONIA 18 0.0015
420 ASPERGILLUS INFECTION 10 0.0015
421 BLINDNESS 62 0.0015
422 MALNUTRITION 17 0.0015
423 MENINGITIS 10 0.0015
424 ARTERIOSPASM CORONARY 6 0.0015
425 PLEURAL EFFUSION 91 0.0015
426 HEPATITIS CHOLESTATIC 9 0.0015
427 CHOLESTASIS 28 0.0015
428 GENERAL PHYSICAL HEALTH DETERIORATION 166 0.0014
429 STOMATITIS 87 0.0014
430 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
431 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
432 PULMONARY MASS 21 0.0014
433 PANCREATITIS 74 0.0014
434 HEPATIC FAILURE 42 0.0014
435 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
436 ENCEPHALOPATHY 34 0.0014
437 BLOOD CALCIUM INCREASED 12 0.0014
438 HYPONATRAEMIA 77 0.0014
439 PHYSICAL DISABILITY 6 0.0014
440 SKIN INFECTION 15 0.0013
441 INTESTINAL PERFORATION 15 0.0013
442 HYPOXIA 47 0.0013
443 THROMBOTIC MICROANGIOPATHY 13 0.0013
444 METABOLIC ENCEPHALOPATHY 4 0.0013
445 CHRONIC SINUSITIS 5 0.0013
446 DECREASED IMMUNE RESPONSIVENESS 13 0.0013
447 BONE MARROW DISORDER 4 0.0013
448 CATHETER SITE INFECTION 5 0.0013
449 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
450 RESPIRATORY DEPRESSION 16 0.0013
451 RESPIRATORY DISTRESS 36 0.0013
452 PULMONARY FIBROSIS 25 0.0013
453 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
454 ORAL INFECTION 5 0.0013
455 PULMONARY HAEMORRHAGE 10 0.0013
456 BLOOD CREATININE DECREASED 4 0.0013
457 ACUTE KIDNEY INJURY 195 0.0013
458 CARDIAC MURMUR 11 0.0013
459 PYELONEPHRITIS 11 0.0013
460 THERAPY NON-RESPONDER 57 0.0013
461 IRIDOCYCLITIS 4 0.0013
462 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
463 LIVER DISORDER 56 0.0013
464 CARDIAC FAILURE 101 0.0013
465 ACUTE PULMONARY OEDEMA 7 0.0012
466 CYSTITIS HAEMORRHAGIC 5 0.0012
467 SKIN TOXICITY 7 0.0012
468 INFECTION 179 0.0012
469 SARS-COV-2 TEST POSITIVE 16 0.0012
470 IMMUNODEFICIENCY 18 0.0012
471 HYPERNATRAEMIA 6 0.0012
472 CARDIAC FAILURE ACUTE 8 0.0012
473 PNEUMONIA BACTERIAL 11 0.0012
474 EOSINOPHILIA 21 0.0012
475 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
476 DERMATITIS ALLERGIC 15 0.0012
477 BK VIRUS INFECTION 4 0.0012
478 TOXIC ENCEPHALOPATHY 6 0.0012
479 MYELODYSPLASTIC SYNDROME 17 0.0012
480 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
481 PURULENT DISCHARGE 5 0.0012
482 WEIGHT DECREASED 326 0.0012
483 SKIN HYPERPIGMENTATION 10 0.0012
484 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
485 GASTROINTESTINAL INFLAMMATION 9 0.0011
486 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
487 IMMOBILE 5 0.0011
488 LUNG DISORDER 56 0.0011
489 BLOOD LACTIC ACID INCREASED 6 0.0011
490 SMALL INTESTINAL OBSTRUCTION 14 0.0011
491 BLOOD ALBUMIN DECREASED 9 0.0011
492 SKIN LESION 31 0.0011
493 DIABETIC KETOACIDOSIS 27 0.0011
494 THERAPY CHANGE 11 0.0011
495 CELLULITIS 56 0.0011
496 DISEASE COMPLICATION 5 0.0011
497 HYPOMAGNESAEMIA 15 0.0011
498 HERPES SIMPLEX 7 0.0011
499 PERFORMANCE STATUS DECREASED 5 0.0011
500 KETOACIDOSIS 8 0.0011
501 CHILLS 125 0.0011
502 HYPOGAMMAGLOBULINAEMIA 7 0.0011
503 SKIN REACTION 15 0.0011
504 DYSGRAPHIA 7 0.0011
505 HERPES ZOSTER 61 0.0011
506 PETECHIAE 11 0.0011
507 SKIN MASS 7 0.0010
508 JAUNDICE 28 0.0010
509 STEVENS-JOHNSON SYNDROME 23 0.0010
510 HAEMOGLOBIN DECREASED 106 0.0010
511 BREAST PAIN 11 0.0010
512 BLOOD POTASSIUM DECREASED 31 0.0010
513 GASTROENTERITIS 15 0.0010
514 RHINOVIRUS INFECTION 4 0.0010
515 LIVER FUNCTION TEST INCREASED 22 0.0010
516 HEPATOMEGALY 10 0.0010
517 PNEUMONIA 325 0.0010
518 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 5 0.0010
519 ABDOMINAL PAIN 232 0.0010
520 FULL BLOOD COUNT DECREASED 20 0.0010
521 TACHYCARDIA 88 0.0010
522 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
523 BRONCHOSPASM 14 0.0010
524 FEMORAL NECK FRACTURE 5 0.0010
525 LEG AMPUTATION 4 0.0010
526 INFUSION SITE EXTRAVASATION 6 0.0010
527 SKIN NECROSIS 5 0.0010
528 HYPOTENSION 192 0.0010
529 SWELLING OF EYELID 6 0.0010
530 NEURALGIA 23 0.0009
531 HYPERPYREXIA 4 0.0009
532 HYPOTHYROIDISM 30 0.0009
533 FACIAL PARALYSIS 8 0.0009
534 MASS 13 0.0009
535 ANURIA 8 0.0009
536 DYSPNOEA EXERTIONAL 35 0.0009
537 GINGIVITIS 5 0.0009
538 ATAXIA 11 0.0009
539 TROPONIN INCREASED 7 0.0009
540 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
541 RENAL TUBULAR NECROSIS 9 0.0009
542 URINE OUTPUT DECREASED 8 0.0009
543 ASPIRATION 10 0.0009
544 BEDRIDDEN 12 0.0009
545 HEPATIC STEATOSIS 17 0.0009
546 FAECALOMA 5 0.0009
547 BLOOD SODIUM DECREASED 17 0.0009
548 HAEMOLYTIC ANAEMIA 8 0.0009
549 DRUG-INDUCED LIVER INJURY 28 0.0009
550 MOTOR DYSFUNCTION 9 0.0009
551 GENERALISED ERYTHEMA 5 0.0009
552 NEOPLASM 10 0.0009
553 SHOCK 20 0.0009
554 MULTI-ORGAN FAILURE 15 0.0009
555 MOUTH SWELLING 5 0.0009
556 SYNOVIAL CYST 4 0.0009
557 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
558 LACTIC ACIDOSIS 28 0.0009
559 HYPOPHAGIA 22 0.0009
560 WEIGHT FLUCTUATION 9 0.0009
561 APPENDICITIS 8 0.0009
562 BONE PAIN 50 0.0009
563 BLINDNESS UNILATERAL 12 0.0008
564 ASCITES 25 0.0008
565 DRUG ERUPTION 15 0.0008
566 RESPIRATORY TRACT INFECTION 22 0.0008
567 METASTASIS 6 0.0008
568 COAGULOPATHY 14 0.0008
569 TYPE 1 DIABETES MELLITUS 5 0.0008
570 HEPATITIS B 5 0.0008
571 ENTEROCOCCAL INFECTION 4 0.0008
572 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
573 BLOOD MAGNESIUM DECREASED 7 0.0008
574 CONJUNCTIVITIS 15 0.0008
575 OXYGEN SATURATION DECREASED 45 0.0008
576 KLEBSIELLA INFECTION 4 0.0008
577 DEHYDRATION 105 0.0008
578 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
579 PRODUCT USE IN UNAPPROVED INDICATION 194 0.0008
580 HEPATITIS ACUTE 5 0.0008
581 CARDIO-RESPIRATORY ARREST 32 0.0008
582 APPETITE DISORDER 5 0.0008
583 RASH ERYTHEMATOUS 36 0.0008
584 FUNGAL INFECTION 25 0.0007
585 PREGNANCY 15 0.0007
586 DECREASED APPETITE 171 0.0007
587 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
588 HEPATIC ENZYME INCREASED 50 0.0007
589 HICCUPS 6 0.0007
590 PHARYNGITIS 9 0.0007
591 LIVER FUNCTION TEST ABNORMAL 21 0.0007
592 EOSINOPHIL COUNT INCREASED 6 0.0007
593 AUTOIMMUNE DISORDER 7 0.0007
594 PELVIC PAIN 13 0.0007
595 FACE OEDEMA 12 0.0007
596 CHOLECYSTITIS ACUTE 4 0.0007
597 RETINAL HAEMORRHAGE 5 0.0007
598 DISEASE RECURRENCE 33 0.0007
599 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
600 ULCER 11 0.0007
601 DEATH 594 0.0007
602 STRESS CARDIOMYOPATHY 4 0.0007
603 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
604 HYPOVOLAEMIA 4 0.0007
605 SPINAL PAIN 8 0.0007
606 RESPIRATORY RATE INCREASED 6 0.0007
607 COVID-19 118 0.0007
608 CARDIOVASCULAR DISORDER 17 0.0007
609 VOMITING 314 0.0007
610 MOUTH ULCERATION 14 0.0007
611 RASH PRURITIC 36 0.0007
612 UVEITIS 9 0.0007
613 FULL BLOOD COUNT ABNORMAL 7 0.0007
614 HAEMODYNAMIC INSTABILITY 5 0.0007
615 NO THERAPEUTIC RESPONSE 8 0.0007
616 CEREBRAL INFARCTION 16 0.0007
617 ACIDOSIS 5 0.0007
618 LARYNGEAL OEDEMA 4 0.0006
619 MENTAL STATUS CHANGES 18 0.0006
620 CHOLANGITIS 4 0.0006
621 CONSTIPATION 140 0.0006
622 RASH 279 0.0006
623 STAPHYLOCOCCAL INFECTION 21 0.0006
624 LEUKAEMIA 6 0.0006
625 RENAL IMPAIRMENT 53 0.0006
626 PNEUMOTHORAX 10 0.0006
627 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
628 HYPERTENSIVE CRISIS 7 0.0006
629 CARDIOGENIC SHOCK 9 0.0006
630 HYPERTHYROIDISM 9 0.0006
631 DERMATITIS 13 0.0006
632 REBOUND EFFECT 7 0.0006
633 DEEP VEIN THROMBOSIS 40 0.0006
634 TOXICITY TO VARIOUS AGENTS 103 0.0006
635 PRODUCT PREPARATION ISSUE 4 0.0006
636 LEUKOCYTOSIS 11 0.0006
637 HOSPICE CARE 6 0.0006
638 HAEMATOCRIT DECREASED 12 0.0006
639 SPINAL COMPRESSION FRACTURE 5 0.0006
640 COLON CANCER 9 0.0006
641 ADVERSE REACTION 8 0.0006
642 HYPOTONIA 6 0.0006
643 PNEUMONIA ASPIRATION 15 0.0006
644 DIARRHOEA 387 0.0006
645 BACTERIAL INFECTION 11 0.0006
646 INTESTINAL OBSTRUCTION 22 0.0006
647 MYOPATHY 5 0.0006
648 VENTRICULAR EXTRASYSTOLES 6 0.0006
649 ACUTE MYOCARDIAL INFARCTION 17 0.0006
650 ADVERSE EVENT 53 0.0006
651 ORTHOSTATIC HYPOTENSION 10 0.0006
652 TRANSFUSION 6 0.0006
653 URINARY RETENTION 19 0.0006
654 HYPOAESTHESIA 85 0.0006
655 BLOOD CREATININE INCREASED 37 0.0006
656 SENSORY DISTURBANCE 9 0.0006
657 SUBDURAL HAEMATOMA 8 0.0006
658 ASTHENIA 210 0.0006
659 BLOOD PRESSURE DECREASED 37 0.0006
660 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
661 MELAENA 12 0.0005
662 PRODUCT ADMINISTRATION ERROR 11 0.0005
663 CONDITION AGGRAVATED 165 0.0005
664 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
665 BLOOD UREA INCREASED 9 0.0005
666 PLATELET COUNT INCREASED 7 0.0005
667 ERYTHEMA MULTIFORME 5 0.0005
668 NEPHROPATHY 5 0.0005
669 RESPIRATORY DISORDER 16 0.0005
670 HYDRONEPHROSIS 4 0.0005
671 TOOTH INFECTION 7 0.0005
672 PAROSMIA 4 0.0005
673 MITRAL VALVE INCOMPETENCE 6 0.0005
674 RENAL FAILURE 70 0.0005
675 PRODUCT USE ISSUE 99 0.0005
676 MYOCARDITIS 6 0.0005
677 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
678 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
679 TACHYPNOEA 7 0.0005
680 NAUSEA 407 0.0005
681 CYANOSIS 8 0.0005
682 PRODUCT PRESCRIBING ERROR 12 0.0005
683 RENAL CYST 4 0.0005
684 HYPERLIPIDAEMIA 6 0.0005
685 HAEMOPTYSIS 14 0.0005
686 BLOOD DISORDER 4 0.0005
687 OEDEMA 27 0.0005
688 GASTRITIS 13 0.0005
689 HYPOTHERMIA 5 0.0005
690 PULMONARY OEDEMA 22 0.0005
691 SYNCOPE 49 0.0005
692 GENERALISED OEDEMA 6 0.0005
693 DISTURBANCE IN ATTENTION 26 0.0005
694 ERYTHEMA 99 0.0005
695 LABORATORY TEST ABNORMAL 14 0.0005
696 COUGH 133 0.0005
697 HYPERSENSITIVITY 88 0.0005
698 DIVERTICULITIS 13 0.0005
699 DRUG RESISTANCE 12 0.0005
700 DECREASED ACTIVITY 5 0.0005
701 HAEMORRHOIDS 9 0.0005
702 ORAL HERPES 9 0.0005
703 PAIN IN JAW 13 0.0005
704 OSTEONECROSIS 15 0.0005
705 GROIN PAIN 4 0.0005
706 IMMUNE SYSTEM DISORDER 6 0.0005
707 COLD SWEAT 8 0.0005
708 IMMUNOSUPPRESSION 4 0.0005
709 DYSPHAGIA 43 0.0005
710 MUSCULOSKELETAL CHEST PAIN 7 0.0005
711 ATRIAL FIBRILLATION 44 0.0005
712 PARAESTHESIA 71 0.0005
713 CARDIAC ARREST 37 0.0004
714 INFLAMMATION 23 0.0004
715 OEDEMA PERIPHERAL 54 0.0004
716 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
717 PULMONARY EMBOLISM 42 0.0004
718 OSTEOMYELITIS 8 0.0004
719 URTICARIA 74 0.0004
720 BODY TEMPERATURE INCREASED 9 0.0004
721 MYOCARDIAL ISCHAEMIA 5 0.0004
722 ABSCESS 7 0.0004
723 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
724 APHASIA 13 0.0004
725 COORDINATION ABNORMAL 6 0.0004
726 DYSPNOEA 243 0.0004
727 DIARRHOEA HAEMORRHAGIC 4 0.0004
728 CHOLELITHIASIS 14 0.0004
729 HEPATIC CIRRHOSIS 8 0.0004
730 DIALYSIS 6 0.0004
731 ALOPECIA 83 0.0004
732 VIRAL INFECTION 14 0.0004
733 CHEST DISCOMFORT 43 0.0004
734 PRODUCTIVE COUGH 20 0.0004
735 HEMIPARESIS 7 0.0004
736 PRODUCT PRESCRIBING ISSUE 9 0.0004
737 ADRENAL INSUFFICIENCY 5 0.0004
738 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
739 DIABETES MELLITUS 31 0.0004
740 METABOLIC ACIDOSIS 13 0.0004
741 DELIRIUM 14 0.0004
742 FEEDING DISORDER 8 0.0004
743 SUBARACHNOID HAEMORRHAGE 4 0.0004
744 GASTROINTESTINAL DISORDER 35 0.0004
745 BLOOD GLUCOSE ABNORMAL 7 0.0004
746 DISORIENTATION 15 0.0004
747 INCONTINENCE 4 0.0004
748 SUDDEN DEATH 4 0.0004
749 MUSCULAR WEAKNESS 42 0.0004
750 PRURITUS 142 0.0004
751 MALAISE 161 0.0004
752 IMPAIRED GASTRIC EMPTYING 5 0.0004
753 CONFUSIONAL STATE 59 0.0004
754 ABDOMINAL DISTENSION 38 0.0004
755 GASTROINTESTINAL PAIN 4 0.0004
756 TREATMENT FAILURE 30 0.0004
757 SKIN DISORDER 12 0.0004
758 WEIGHT INCREASED 80 0.0004
759 PERICARDITIS 6 0.0004
760 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
761 ABDOMINAL PAIN LOWER 9 0.0004
762 HAEMATEMESIS 9 0.0004
763 STATUS EPILEPTICUS 4 0.0004
764 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
765 BRONCHITIS 26 0.0004
766 PARALYSIS 5 0.0003
767 RASH GENERALISED 9 0.0003
768 METASTASES TO LUNG 4 0.0003
769 DEAFNESS 9 0.0003
770 APATHY 5 0.0003
771 METASTASES TO LIVER 6 0.0003
772 FATIGUE 265 0.0003
773 HAEMORRHAGE INTRACRANIAL 5 0.0003
774 URINARY TRACT INFECTION 57 0.0003
775 HEPATITIS C 4 0.0003
776 DRUG INTOLERANCE 32 0.0003
777 UNEVALUABLE EVENT 25 0.0003
778 PHARYNGEAL OEDEMA 5 0.0003
779 INJECTION SITE EXTRAVASATION 4 0.0003
780 PRURITUS GENERALISED 7 0.0003
781 GYNAECOMASTIA 10 0.0003
782 RENAL DISORDER 15 0.0003
783 PHOTOPHOBIA 6 0.0003
784 HOSPITALISATION 49 0.0003
785 ANGIOEDEMA 14 0.0003
786 RED BLOOD CELL COUNT DECREASED 9 0.0003
787 THERAPEUTIC RESPONSE DECREASED 19 0.0003
788 ORAL PAIN 7 0.0003
789 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
790 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
791 NODULE 4 0.0003
792 RENAL FAILURE ACUTE 13 0.0003
793 ECZEMA 16 0.0003
794 VENTRICULAR TACHYCARDIA 5 0.0003
795 BLISTER 17 0.0003
796 VISUAL ACUITY REDUCED 10 0.0003
797 MYALGIA 51 0.0003
798 DYSURIA 11 0.0003
799 CORONARY ARTERY DISEASE 9 0.0003
800 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
801 SEIZURE 34 0.0003
802 CIRCULATORY COLLAPSE 5 0.0003
803 EMOTIONAL DISORDER 9 0.0003
804 FEMUR FRACTURE 9 0.0003
805 PARANOIA 5 0.0003
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
807 DRUG INEFFECTIVE 378 0.0003
808 APHONIA 4 0.0003
809 RASH MACULAR 10 0.0003
810 FLUSHING 29 0.0003
811 CYSTITIS 9 0.0003
812 MOVEMENT DISORDER 9 0.0003
813 CEREBRAL HAEMORRHAGE 10 0.0003
814 CHEST PAIN 51 0.0003
815 HYPERHIDROSIS 35 0.0003
816 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
817 BLOOD COUNT ABNORMAL 4 0.0003
818 EPILEPSY 8 0.0003
819 THROAT TIGHTNESS 7 0.0003
820 NERVOUS SYSTEM DISORDER 8 0.0003
821 PRESCRIBED UNDERDOSE 5 0.0003
822 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
823 HYPOGLYCAEMIA 12 0.0002
824 TASTE DISORDER 5 0.0002
825 INFLUENZA 27 0.0002
826 DYSARTHRIA 9 0.0002
827 ABDOMINAL PAIN UPPER 49 0.0002
828 OROPHARYNGEAL PAIN 22 0.0002
829 BACK PAIN 55 0.0002
830 WHEEZING 14 0.0002
831 RETCHING 5 0.0002
832 IMPAIRED WORK ABILITY 5 0.0002
833 ERECTILE DYSFUNCTION 6 0.0002
834 HAEMATURIA 8 0.0002
835 UNRESPONSIVE TO STIMULI 6 0.0002
836 FALL 77 0.0002
837 SWELLING FACE 15 0.0002
838 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
839 GAIT DISTURBANCE 43 0.0002
840 CARDIAC FAILURE CONGESTIVE 18 0.0002
841 RASH PAPULAR 5 0.0002
842 SNEEZING 5 0.0002
843 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
844 GASTROENTERITIS VIRAL 4 0.0002
845 MYOCARDIAL INFARCTION 38 0.0002
846 DEMENTIA 6 0.0002
847 THERAPY CESSATION 11 0.0002
848 COGNITIVE DISORDER 10 0.0002
849 SKIN EXFOLIATION 18 0.0002
850 FRACTURE 4 0.0002
851 THROMBOSIS 17 0.0002
852 COMA 10 0.0002
853 GAIT INABILITY 7 0.0002
854 LETHARGY 12 0.0002
855 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
856 SINUSITIS 21 0.0002
857 NASAL CONGESTION 12 0.0002
858 ILLNESS 21 0.0002
859 KIDNEY INFECTION 4 0.0002
860 DISABILITY 4 0.0002
861 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
862 HEART RATE INCREASED 20 0.0002
863 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
864 EPISTAXIS 15 0.0002
865 FLUID RETENTION 10 0.0002
866 SKIN BURNING SENSATION 14 0.0002
867 INFLUENZA LIKE ILLNESS 16 0.0002
868 SKIN ULCER 5 0.0002
869 PULMONARY HYPERTENSION 4 0.0002
870 MUSCULOSKELETAL PAIN 10 0.0002
871 SPEECH DISORDER 10 0.0002
872 PAIN IN EXTREMITY 56 0.0002
873 ARRHYTHMIA 9 0.0002
874 HALLUCINATION, VISUAL 4 0.0002
875 DYSPHONIA 11 0.0002
876 EAR INFECTION 5 0.0002
877 EATING DISORDER 4 0.0002
878 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
879 TREMOR 31 0.0002
880 PAIN OF SKIN 5 0.0002
881 BALANCE DISORDER 16 0.0002
882 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
883 PALLOR 5 0.0002
884 DYSPEPSIA 18 0.0002
885 NECK PAIN 10 0.0002
886 WOUND 5 0.0002
887 ARTHRALGIA 74 0.0002
888 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
889 NEPHROLITHIASIS 8 0.0002
890 MUSCLE SPASMS 32 0.0002
891 HYPERKALAEMIA 6 0.0002
892 AMNESIA 11 0.0002
893 LACRIMATION INCREASED 5 0.0002
894 HYPERTENSION 35 0.0002
895 TREATMENT NONCOMPLIANCE 9 0.0002
896 LOSS OF CONSCIOUSNESS 21 0.0002
897 RECTAL HAEMORRHAGE 7 0.0002
898 DYSGEUSIA 12 0.0002
899 MENTAL DISORDER 7 0.0002
900 AGEUSIA 4 0.0002
901 PAIN 98 0.0002
902 BLOOD GLUCOSE INCREASED 30 0.0002
903 FLATULENCE 9 0.0002
904 THROAT IRRITATION 7 0.0002
905 PERIPHERAL SWELLING 24 0.0002
906 HAEMATOMA 4 0.0002
907 INSOMNIA 41 0.0002
908 MOBILITY DECREASED 11 0.0002
909 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
910 LIP SWELLING 5 0.0001
911 CARDIAC DISORDER 14 0.0001
912 TYPE 2 DIABETES MELLITUS 5 0.0001
913 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
914 FREQUENT BOWEL MOVEMENTS 4 0.0001
915 DISCOMFORT 9 0.0001
916 RESPIRATORY ARREST 4 0.0001
917 DRUG INTERACTION 23 0.0001
918 FEELING COLD 4 0.0001
919 BURNING SENSATION 10 0.0001
920 ARTHRITIS 11 0.0001
921 ANGINA PECTORIS 4 0.0001
922 DRUG EFFECT INCOMPLETE 5 0.0001
923 PANIC ATTACK 5 0.0001
924 HEADACHE 86 0.0001
925 ABDOMINAL DISCOMFORT 23 0.0001
926 DYSSTASIA 4 0.0001
927 PSYCHOTIC DISORDER 4 0.0001
928 EYE SWELLING 5 0.0001
929 COLITIS ULCERATIVE 6 0.0001
930 BRADYCARDIA 7 0.0001
931 VERTIGO 8 0.0001
932 SKIN DISCOLOURATION 6 0.0001
933 PALPITATIONS 15 0.0001
934 SWOLLEN TONGUE 4 0.0001
935 DIZZINESS 62 0.0001
936 PRODUCT DOSE OMISSION ISSUE 36 0.0001
937 RHABDOMYOLYSIS 5 0.0001
938 POLLAKIURIA 5 0.0001
939 HALLUCINATION 9 0.0001
940 FEELING HOT 7 0.0001
941 SLEEP DISORDER 8 0.0001
942 FEELING ABNORMAL 27 0.0001
943 CRYING 4 0.0001
944 UNDERDOSE 8 0.0001
945 VISION BLURRED 15 0.0001
946 RHINORRHOEA 7 0.0001
947 SWELLING 10 0.0001
948 DRY SKIN 14 0.0001
949 NEOPLASM MALIGNANT 7 0.0001
950 SOMNOLENCE 21 0.0001
951 PRODUCT STORAGE ERROR 9 0.0001
952 MEMORY IMPAIRMENT 14 0.0001
953 NASOPHARYNGITIS 18 0.0001
954 ROAD TRAFFIC ACCIDENT 4 0.0001
955 AGITATION 7 0.0001
956 DEPRESSED MOOD 5 0.0001
957 ANXIETY 26 0.0001
958 HAEMATOCHEZIA 5 0.0001
959 MEDICATION ERROR 5 0.0001
960 ADVERSE DRUG REACTION 8 0.0001
961 DEPRESSION 19 0.0001
962 ASTHMA 9 0.0001
963 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
964 CEREBROVASCULAR ACCIDENT 12 0.0001
965 CONVULSION 4 0.0001
966 CATARACT 4 0.0001
967 HAEMORRHAGE 7 0.0001
968 IRRITABILITY 4 0.0001
969 HOT FLUSH 5 0.0001
970 ILL-DEFINED DISORDER 4 0.0001
971 OVERDOSE 14 0.0001
972 NO ADVERSE EVENT 11 0.0001
973 BLOOD PRESSURE INCREASED 9 0.0001
974 ACNE 4 0.0001
975 CHRONIC KIDNEY DISEASE 4 0.0001
976 CONTUSION 5 0.0001
977 DRY MOUTH 4 0.0000
978 INJECTION SITE ERYTHEMA 6 0.0000
979 MUSCULOSKELETAL STIFFNESS 4 0.0000
980 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
981 INCORRECT DOSE ADMINISTERED 10 0.0000
982 SUICIDAL IDEATION 4 0.0000
983 MIGRAINE 4 0.0000
984 DRUG DOSE OMISSION 4 0.0000
985 INJECTION SITE PAIN 5 0.0000